Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK 2.080
-0.060 (-2.80%)
Nov 21, 2024, 4:25 PM CET
Arctic Bioscience AS Revenue
Arctic Bioscience AS had revenue of 17.20M NOK in the half year ending June 30, 2024, with 19.46% growth. This brings the company's revenue in the last twelve months to 31.88M, down -18.57% year-over-year. In the year 2023, Arctic Bioscience AS had annual revenue of 33.76M, down -2.07%.
Revenue (ttm)
31.88M
Revenue Growth
-18.57%
P/S Ratio
1.65
Revenue / Employee
1.88M
Employees
355
Market Cap
52.77M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nordhealth AS | 513.12M |
| Medistim ASA | 541.82M |
| Carasent ASA | 264.80M |
| Photocure ASA | 526.25M |
| Nykode Therapeutics AS | 69.44M |
| ArcticZymes Technologies ASA | 110.76M |
| Gentian Diagnostics ASA | 154.12M |
| Hofseth BioCare ASA | 248.08M |